CMV strains occurs in various patient populations including both immune-competent and immunocompromised subjects [18][19][20][21][22][23].In Congenital CMV infection, there is strain diversity and infection with multiple CMV strains occurs in congenital CMV infection. Neither, the pathogenesis nor the long-term effect of specific or co-infecting genotypes is currently known [24]. CMV genome is composed of linear, double-stranded DNA, surrounded by a matrix protein lining containing phosphoproteins, which causes the dysregulation of the host's cell cycle. The protein lining is enveloped by several glycoproteins that are necessary for the virus's infectivity, including entrance to the host cell, cell-to-cell dissemination and maturation [25]. The fusion between the virus and the cell is mediated by the viral glycoprotein [25,26], which is followed by the entrance of the nucleocapsid and protein lining of the host cell cytoplasm. The nuclei are translocated, an infection marker that may be detected in serum within an hour. Many host cells act as the main reservoirs of CMV, which includes the monocytes, fibroblasts, myeloid cells, epithelial and endothelial cells [25]. Endothelial cells and macrophages play an important role in latency and seem to be critical for maintaining CMV in the host [27]. After cell infection, viral replication begins within 12-24 hours, with the cytopathic effect seen in-vitro after 7-14 days [28]. Through inhibiting RNA formation, CMV has the ability of thwarting its host's immune response, by preventing antigen presentation mechanism and blocking apoptosis [21]. These mechanisms may lead to reactivation of a latent infection, often seen in transplant patients [29]. Currently, there are three forms of active CMV infection: a) primary infection, when the virus infects a CMV-naive subject; b) endogenous infection in CMVseropositive individuals who undergo reactivation from latency, and c) exogenous reinfection in previously infected individuals who acquire infection by a different strain [30]. Either active or latent CMV infection induces sustained systemic inflammatory responses that are accompanied by a type 1 cytokine signature [31]. Viral persistence is established in all infected individuals and is chronically productive or occurs as a latent infection in
Abbreviations AbstractCMV is a common complex viral infection that affects patients at all ages, especially newborns. It causes a lifelong infection with a frequency of approximately 80% of the population will become infected by age 40. Most CMV infection is silent infection (no symptoms), however, in immunocompromised individuals, a symptomatic infection persists with few medical treatments or vaccine currently available. Coinfection of CMV with other viruses had drawn much attention in the last decade, as diagnostic methodologies became more reliable, and many cases have been reported. The long-term relationships between immune responses, viral load, and most importantly, disease progression in those who are persistently infected with...